449 related articles for article (PubMed ID: 27443962)
1. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
Haque R; Nazir A
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
[TBL] [Abstract][Full Text] [Related]
2. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
Shi YC; Pan TM; Liao VH
J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
[TBL] [Abstract][Full Text] [Related]
4. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
Godini R; Pocock R; Fallahi H
PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
[TBL] [Abstract][Full Text] [Related]
5. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
6. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
7. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
Li J; Cui X; Ma X; Wang Z
Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
[TBL] [Abstract][Full Text] [Related]
8. Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1.
Lu X; Zhang Y; Li H; Jin Y; Zhao L; Wang X
Neurosci Lett; 2021 Sep; 761():136114. PubMed ID: 34274434
[TBL] [Abstract][Full Text] [Related]
9. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
Wang X; Yi K; Zhao Y
Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta (Aβ1-42)-induced paralysis in Caenorhabditis elegans is reduced by restricted cholesterol supply.
Regitz C; Wenzel U
Neurosci Lett; 2014 Jul; 576():93-6. PubMed ID: 24909620
[TBL] [Abstract][Full Text] [Related]
12. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
13. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
14. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
15. Diterpenoid Caesalmin C Delays Aβ-Induced Paralysis Symptoms via the DAF-16 Pathway in
Zhang ZP; Bai X; Cui WB; Chen XH; Liu X; Zhi DJ; Zhang ZX; Fei DQ; Wang DS
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743309
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
17. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease-related pathology via autophagy induction.
Long T; Chen X; Qin DL; Zhu YF; Zhou YJ; He YN; Fu HJ; Tang Y; Yu L; Huang FH; Wang L; Yu CL; Law BY; Wu JM; Wu AG; Zhou XG
Phytother Res; 2023 Oct; 37(10):4639-4654. PubMed ID: 37394882
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model of
Leiteritz A; Schmiedl T; Baumanns S; Wenzel U
Nutr Neurosci; 2021 Feb; 24(2):82-89. PubMed ID: 30905309
[No Abstract] [Full Text] [Related]
20. Black mulberry (Morus nigra) fruit extract alleviated AD-Like symptoms induced by toxic Aβ protein in transgenic Caenorhabditis elegans via insulin DAF-16 signaling pathway.
Wang E; Wang N; Zou Y; Fahim M; Zhou Y; Yang H; Liu Y; Li H
Food Res Int; 2022 Oct; 160():111696. PubMed ID: 36076399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
